FDA, DEA, BIS, OFAC: a four-agency primer for medical exporters.
The FDA, DEA, BIS and OFAC are four separate United States authorities, and each answers a different question about the same shipment. The FDA regulates food, drugs, biologics, devices and cosmetics for the US market. The DEA regulates controlled substances. The Bureau of Industry and Security controls sensitive and dual-use goods leaving the US. The Office of Foreign Assets Control administers trade sanctions, which turn on who and where rather than what. One shipment can engage all four.
Most delays described as regulatory review are really the result of finding out late which authority had a say. The four do not share a portal, a form, or a shared definition of a complete submission, and a clean answer from one says nothing about the other three. A consignment can satisfy every product rule that applies to it and still sit still because a counterparty appears on a sanctions list, or because an instrument contains a component subject to export control. If you are still working out what you are buying and where it is going, scoping a medical product inquiry settles the two facts that decide which of the four apply.
Four agencies, four different questions
| Agency | What it administers | The question it answers |
|---|---|---|
| FDA — Food and Drug Administration | Food, human and animal drugs, biologics, medical devices, cosmetics and tobacco for the American market, administered from within the Department of Health and Human Services. | What is this item, how is it labelled, and how is it represented? The authority attaches to the product and to the market it enters. |
| DEA — Drug Enforcement Administration | Controlled substances: who may manufacture, distribute, import and export them, and in what quantities. | Does the item contain a scheduled active ingredient? Most medical consumables never touch it; a product containing one always does. |
| BIS — Bureau of Industry and Security | Export controls over dual-use and other sensitive goods leaving the United States, administered from the Department of Commerce against a published control list. | Is it controlled for export, and on what basis? The answer turns on the destination, the end user and the end use. |
| OFAC — Office of Foreign Assets Control | Economic and trade sanctions: country programmes, restricted parties and sectoral restrictions, administered by the Treasury Department. | Who sits on either side of the transaction? Sanctions attach to the parties rather than to the goods. |
The four do not coordinate their reviews, and a determination by one has no standing with the others. These are United States authorities; other destinations have their own equivalents, and the same four questions generally arise there under different names. Which of them is in play comes down to three things: what the product is, where it is going, and who sits on either side of the transaction.
Which agencies apply to this shipment
Parties first, then product, then movement
Screen the parties first, because sanctions are the one layer that can stop a transaction whatever the goods are. The buyer, the consignee, the forwarder, the carrier and the paying bank are all checked against the sanctions lists published by Treasury before anything else is worth doing, because a restricted party ends the shipment regardless of how clean the product is. Next comes what the product is: entering the American market, the FDA's rules attach to the item itself, and a product containing a scheduled substance carries the DEA's rules with it. Then how the goods move. Export control reaches items leaving the United States, and how an item is classified decides whether an authorisation is required — items with no listed classification still have to be screened for restricted end users and end uses. These are orientation questions rather than determinations. Classification, scheduling and licence decisions belong to the agencies themselves, and the boundary between this site's general guidance and professional advice is set out on the medical and regulatory disclaimer page.
When one shipment engages several agencies, sequence the checks
- Screen the parties first — buyer, consignee, forwarder, carrier and bank. It is the quickest check to run and the only one that can end the transaction on its own.
- Establish what the product is and what it must satisfy in the country it is entering: the standard it meets, its labelling, and how it will be represented there.
- Determine whether the item is subject to export control from its country of origin, counting the components, software and technical data inside an assembled product rather than the finished goods alone.
- Check whether a scheduled substance is present, at what level, and what the destination requires before it may be imported.
- Pull the product-specific evidence into a single file — authorisations, certificates, batch records — so a question from any of the four is answered from the same document set rather than reconstructed under pressure.
- Only then commit to a delivery date, because every step above can move it.
What to have ready before anyone asks
The documents reviewers return to most often
- Business identity: the legal name, registration details and the number that will appear on the shipment documents. A trading name that does not match the registered name is one of the most common reasons a file comes back for clarification.
- Product identity: the exact item, the standard it meets, its labelling as it will arrive, and its classification or scheduling status in both the country of origin and the destination.
- Quality evidence tied to the item rather than to the company — records issued against a lot, plus a statement of the conditions under which the goods were made and will be held.
- Destination authorisation: whatever the destination requires before the product may be sold or used there, confirmed against that destination's own published requirements rather than inferred from a certificate issued somewhere else.
- End user and end use: who will use the item, for what purpose, and where it goes after arrival — the question on which export control review turns.
- A named individual who owns the file and answers directly, so a question is not waiting in a shared inbox.
What review looks like from the buyer's side
No agency's review can be promised in advance, and a supplier's assurance is not a commitment from a regulator. In practice a file either clears without comment, comes back with questions, or is held for information nobody anticipated — and only the middle outcome is predictable in advance, which is why a schedule built around a single assumed clearance date is built on a guess. The workable response is to keep everything that does not depend on the review moving while it runs: specification, supplier qualification and documentation advance in parallel, which is what how global sourcing runs describes as one accountable chain rather than a relay between intermediaries. When the requirement itself is defined, the quote form is where to begin, and contact is the route for a question that does not fit a form.
Straight answers.
Which agency applies to my shipment first?
Sanctions, usually. Screen the counterparties before anything else, because a restricted party ends a transaction whatever the goods are. After that the product decides: what the item is determines whether product-market rules and controlled-substance rules reach it, and where the goods physically move from and to determines whether export controls do.
Does one agency's approval clear the others?
No. The four authorities do not share submissions and do not accept each other's determinations. A product authorisation says nothing about whether a counterparty may be paid, and a clean sanctions screen says nothing about whether an item may leave the country. Each has to be settled on its own terms, and a gap in any one of them can stop the shipment.
Do all four agencies apply to every medical shipment?
Rarely. Many medical consumables never touch controlled-substance rules, and plenty of goods are not listed for export control purposes. What nearly every transaction does face is counterparty screening, because sanctions apply to the parties and the jurisdiction rather than to the product. The task is to establish which of the four apply, not to assume that all of them do.
Where do I confirm a regulatory requirement for my shipment?
With the authority that owns the question: product questions to the regulator for the market the goods are entering, controlled-substance questions to the corresponding narcotics authority, classification and end-use questions to the export control authority, and sanctions questions to the treasury authority that publishes the lists. This page is general guidance rather than advice, and the boundary is set out on our disclaimer page.
